T2 Inflammation in Inflammatory Airway Disease: Basis of new Treatment Options

Klimek, L. and Hagemann, J. and Welkoborsky, H. J. and Cuevas, M. and Casper, I. and Forster-Rurmann, U. and Klimek, F. and Hintschich, C. A. and Huppertz, T. and Bergmann, K. -Ch. and Tomazic, P. V. and Bergmann, C. and Becker, S. (2022) T2 Inflammation in Inflammatory Airway Disease: Basis of new Treatment Options. LARYNGO-RHINO-OTOLOGIE, 101 (02). pp. 96-108. ISSN 0935-8943, 1438-8685

Full text not available from this repository. (Request a copy)
Item Type: Article
Uncontrolled Keywords: EXHALED NITRIC-OXIDE; SEVERE EOSINOPHILIC ASTHMA; INNATE LYMPHOID-CELLS; EXACERBATED RESPIRATORY-DISEASE; CLINICAL-PRACTICE GUIDELINE; ENDOSCOPIC SINUS SURGERY; REAL-WORLD EXPERIENCE; CHRONIC RHINOSINUSITIS; ALLERGIC RHINITIS; DOUBLE-BLIND; Alarmine; CRS; CRSwNP; epitheliale Immunregulation; T2-Inflammation; Tezepelumab; TSLP
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Hals-Nasen-Ohren-Heilkunde
Depositing User: Dr. Gernot Deinzer
Date Deposited: 21 Sep 2022 08:03
Last Modified: 21 Sep 2022 08:03
URI: https://pred.uni-regensburg.de/id/eprint/47786

Actions (login required)

View Item View Item